Understanding the pneumococcal landscape and vaccine solutions

AdobeStock_1491327085 - image for home page-01

This clinical update, presented by Prof Shabir Madhi and Prof Nicolette du Plessis, discusses the pneumococcal landscape in South Africa and advises on the appropriate use of vaccines to protect against hospitalisation and death from invasive pneumococcal disease (IPD)

Learning objectives:

You will learn

  • The pathogenesis and epidemiology of Streptococcus pneumoniae in South Africa
  • The impact of pneumococcal conjugate vaccines (PCVs) on the burden of pneumococcal disease morbidity and mortality in South Africa, and challenges that hinder greater vaccine coverage
  • Current global and local trends in the prevention of invasive pneumococcal disease
  • Global recommendations when considering a transition to extended-valency pneumococcal conjugate vaccination in children <2 years
  • The indication for PCV15, new to South Africa, and an overview of PCV15 paediatric clinical evidence.
ATTENTIONKindly note that if you attended the live webinar and completed the questions after the event, you have already received CPD point/s and will not be permitted to receive additional points for the on-demand video and questions. Should this occur, the HPCSA will only record CPD point/s from the live webinar, invalidating any additional CPD points from this activity.Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.

To access this module, please register or login: